Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 14, 2024 (Week 37)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 47 NC 2,922 4,580
New England - NC 47 74
Connecticut - NC - -
Maine - NC 9 36
Massachusetts - NC - -
New Hampshire - NC 13 17
Rhode Island - NC 25 21
Vermont - NC - -
Middle Atlantic 3 NC 107 390
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 161
Pennsylvania 3 NC 107 229
East North Central 31 NC 1,476 1,801
Illinois - NC 11 526
Indiana - NC 211 274
Michigan - NC 126 234
Ohio 31 NC 1,010 738
Wisconsin - NC 118 29
West North Central - NC 98 191
Iowa - NC 39 65
Kansas - NC 55 66
Minnesota - NC - 51
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 8
South Dakota - NC 4 1
South Atlantic 13 NC 388 593
Delaware - NC 15 11
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 222
Maryland - NC - -
North Carolina - NC - 119
South Carolina - NC - -
Virginia 13 NC 300 182
West Virginia - NC 73 59
East South Central - NC 60 151
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC 60 151
Tennessee - NC - -
West South Central - NC - 17
Arkansas - NC - -
Louisiana - NC - 17
Oklahoma - NC - -
Texas U NC U U
Mountain - NC 730 711
Arizona - NC 693 575
Colorado - NC - -
Idaho - NC - -
Montana - NC 6 1
Nevada - NC 1 82
New Mexico - NC - -
Utah - NC 30 52
Wyoming - NC - 1
Pacific - NC 16 652
Alaska - NC - -
California - NC - 560
Hawaii - NC - 13
Oregon - NC 16 20
Washington - NC - 59
U.S. Territories - NC - 125
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC - -
Puerto Rico - NC - 125
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 -
Total 47 NC 2,924 4,705
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.